# A Cross-sectional Study of COPD and Symptom Variability in MEA Countries

> **NCT03425760** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 3254 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03425760
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-07
- **Primary completion:** 2017-03-31
- **Final completion:** 2017-03-31
- **Target enrollment:** 3254 (ACTUAL)
- **Last updated:** 2018-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03425760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03425760, "A Cross-sectional Study of COPD and Symptom Variability in MEA Countries". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03425760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*